Topic

Articles

Snapdragon Chemistry concentrates in API batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges.

Cambrex Acquires Snapdragon Chemistry

The Vault Quality Suite will help Adare simplify its quality operations across its sites in the United States, France, and Italy. 

Adare Pharma Solutions Coordinating Quality with Veeva Vault Quality Suite

It is intended to identify the most prevalent and immunogenic targets in solid tumors by uniquely combining high-diversity target libraries with active machine learning. 

Boehringer Ingelheim, 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

Astrea Bioseparations has acquired Delta Precision, a manufacturer of chromatography columns for biomanufacturing.

Astrea Bioseparations Acquires Delta Precision

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Bio/pharma has evolved and adapted to a variety of challenges in 2022, but what might be on the cards for the industry in 2023?

Opening Up Opportunities in 2023

CMOs are hoping to grow outsourcing to significantly higher levels in many different areas, with a focus on analytical testing, toxicity testing, and fill/finish operations.

The Growth and Emergence of Technology in the Outsourcing Space

In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.

Reaction Biology Acquires Bioassay GmbH for Increasing Large Molecule Capabilities 

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

Cytiva Acquires CEVEC, Boosts Cell Line Development Capabilities

H.I.G. Capital’s portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals.

H.I.G. Capital Acquires Morningside Healthcare and Morningside Pharmaceuticals

Pfizer has completed its acquisition of Biohaven Pharmaceuticals for approximately $11.6 billion.

Mergers and Acquisitions